DiaMedica Therapeutics is a clinical-stage biopharmaceutical company that is developing innovative treatments where there is a significant unmet clinical need or where no current therapies are available with the focus on neurological and kidney diseases.

Biotechnology

DiaMedica Therapeutics

Rick Pauls

Beth Larson-DeBruzzi

David Wambeke

Scott Kellen, CPA (inactive)

Julie Vanorsdel Daves

Dominic R. Cundari

Kirsten Gruis

Scott Kellen

Scientific Advisory Team

Leadership Team

Finance and Administrative Team

Clinical Operations Team

DiaMedica Therapeutics

Org chart

Teams

Scientific Advisory Team

Leadership Team

Finance and Administrative Team

Clinical Operations Team

Similar companies